A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
暂无分享，去创建一个
M. Ayers | S. Bielack | C. Herzog | N. Daw | Á. Lassaletta | O. Monge | R. Gorlick | S. Yao | K. Pathiraja | D. Mauro | P. Anderson | K. Skubitz | Joseph Rubino | D. Hille | B. Lu | É. Boldrini | M. Nebozhyn | Zsuzanna Pápai